Michael A. Bookman, MD
Professor of Medicine
University of Arizona Cancer Center
University of Arizona Cancer Center
1515 N Campbell Ave, Rm 1903
Tucson,
AZ
USA
85724-5024
Papers:
41 - Featured Poster
The impact and interaction of preoperative disease burden, complex surgery, and residual disease in patients with advanced stage ovarian cancer and the effect on on patient survival: A GOG 182 analysis
46 - Featured Poster
Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced-stage serous ovarian or primary peritoneal cancer: a Gynecologic Oncology Group (GOG) study
60 - Scientific Plenary
Predictive model for preoperative determination of microscopic residual disease at the time of primary cytoreduction in patients with advanced-stage epithelial ovarian cancer: a Gynecologic Oncology Group (GOG) 182 analysis
62 - Scientific Plenary
Ascites predicts degree of treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, Fallopian tube, and peritoneal cancers
237 - Poster Session A
Clinicopathologic benchmark for prognostic modeling of advanced epithelial ovarian cancer long-term survival: a Gynecologic Oncology Group (GOG) analysis
Lecturette